First GMP-compliant hot melt device for pharma applications

4 Apr 2018

The IHD series has been specially designed for coating and granulating pharmaceutical products with hot greases and waxes.

Romaco Innojet has launched the first GMP-compliant hot melt coating device specifically for use in the pharmaceutical industry. The IHD series for processing hot melt coatings can be supplied as a laboratory or pilot-scale machine.

First GMP-compliant hot melt device for pharma applications
Romaco Innojet IHD 5 hot melt device.

The IHD series from Romaco Innojet was specially designed for coating and granulating pharmaceutical products with hot greases and waxes. GMP compliance was a key development priority for these CIP capable devices, particularly regarding the validation of the cleaning processes. All sealing points, gaps and enclosed spaces were eliminated for this reason and flange connections reduced to a minimum. The hot melt coating flows through straight tubes to prevent any build-up of product residues. All product-contacted surfaces inside the IHD devices are positioned in such a way that they are fully visible and suitable for swab testing. Once the device has been cleaned, it can be opened up quickly and easily for inspection. The Romaco Innojet IHD series successfully avoids cross-contamination thanks to the hygienic design with no dead spaces.

To allow precise and uniform heat distribution, the Innojet IHD was designed as a heatable monobloc integrating all functional components. The melting container, dosing unit and valve block are all included in the same thermal cycle, which means they do not have to be heated and insulated separately. The compact hot melt coating devices are connected via a trace heated tube to the processing machines in the Romaco Innojet VENTILUS series whenever this is required by the application. The Innojet IHD feeds the hot melt with a pulsation-free dosing piston as standard, so that the coating is applied to the product absolutely evenly. The central bottom spray nozzle on the Innojet machine enables both the temperature and the size of the droplets with which the product particles are coated to be precisely defined. The Romaco Innojet air flow bed technology ensures homogeneous and controllable flow conditions in the container of the processing machines. The laboratory-scale version of the hot melt coating device (Innojet IHD 5) is designed to handle batches of up to 5 L whereas the pilot-scale machine (Innojet IHD 50) can process up to 50 L.

Benefits of hot melt coated formulations

Innojet’s IHD technology lets pharmaceutical manufacturers reap the previously unattainable benefits of hot melt coatings. Unlike aqueous alternatives, hot melt coatings contain no solvents which would have to be evaporated again after they have been sprayed on. Hot melt coatings solidify directly on the product, resulting in up to 85% shorter processing times. Less spray is required for hot melt coating processes because the formulations are solvent-free. What’s more, since there is no need to heat the air to dry the product, energy efficiency is improved. Hot melt coating is not only an extremely economical and efficient production process; it is also very versatile; for example, for moisture barriers, taste masks or delayed API release.

Read More

Related news

India to have strongest global growth in 2019?

India to have strongest global growth in 2019?

4 Dec 2018

Main drivers cited as ‘high-growth domestic market’ and ‘expanding manufacturing exports’.

Read more 
Record year for pharma packaging and drug delivery innovation

Record year for pharma packaging and drug delivery innovation

13 Nov 2018

Event sees more innovation centralising at the Paris hub with entries for the awards and Start-up Hub opening.

Read more 
bioLIVE to merge with BioProduction Congress for 2019 event

bioLIVE to merge with BioProduction Congress for 2019 event

7 Nov 2018

BioProduction’s content platform will be added to the bioLIVE exhibition, creating one of the world’s largest event hubs for the bio industry.

Read more 
Global pharma set for strong year

Global pharma set for strong year

23 Oct 2018

Eight of the top ten pharma nations reporting improving market conditions.

Read more 
New portable and ready-to-use upper respiratory drug delivery solution

New portable and ready-to-use upper respiratory drug delivery solution

11 Oct 2018

PureHale is valuable to pharmaceutical partners seeking a system that can carry a range of formulations and comes in various container sizes.

Read more 
CPhI Worldwide announces the winners  of the 15th Pharma Awards

CPhI Worldwide announces the winners of the 15th Pharma Awards

10 Oct 2018

17 winners chosen from over 250 entries, with Nanobiotix winning both ‘CEO‘ and ‘Pharma Company of the Year’ categories.

Read more 
CMOs to benefit from double digit approvals for ADCs in the next 3 years

CMOs to benefit from double digit approvals for ADCs in the next 3 years

9 Oct 2018

Therapeutic ADC market expected to reach $4 billion by 2023.

Read more 
Movement on the market reflected at CPhI Worldwide 2018

Movement on the market reflected at CPhI Worldwide 2018

3 Oct 2018

Companies new to CPhI to showcase an exciting range of products and services ranging from electroceuticals to refrigerant alternatives.

Read more 
Bioconjugation expertise and increased productivity in bio over next 5 years

Bioconjugation expertise and increased productivity in bio over next 5 years

28 Sep 2018

Smaller bioreactors and high-density perfusion techniques needed as manufacturing makes significant efficiency improvements.

Read more 
Croda to showcase ProSilic drug delivery technology

Croda to showcase ProSilic drug delivery technology

25 Sep 2018

New technology will give Croda’s customers access to the next generation of targeted and controlled drug delivery.

Read more